Using CRISPR Interference as a Therapeutic Approach to Treat TGFbeta2-Induced Ocular Hypertension and Glaucoma.

Rayana NP, Sugali CK, Dai J, Peng M, Liu S, Zhang Y, Wan J, Mao W
Invest Ophthalmol Vis Sci. 2021 Sep 2;62(12):7. doi: 10.1167/iovs.62.12.7. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.